Daily news
Using evidence as the guiding star, the @ducrest Twitter timeline consists of the latest scientific publications in dermatology, cosmetic dermatology, cosmetics and Home-Use devices. Here you will find interesting information gleaned from science and technology sources as well as the lay press.
The skin you live in
thehealthyskinblog.org/the-skin-you-l… #skin #dermatology
RT @galderma: Galderma gain rights Restylane, Perlane, Sculptra Dysport in US, Canada prn.to/1iuBIVF #dermatology Nestle Skin Health
Regenerative Medicine and the Future of Plastic Surgery journals.lww.com/plasreconsurg/… #plasticsurgery #cosmeticsurgery
Trends and Drivers of the Aesthetic Market during a Turbulent Economy @prsjournal journals.lww.com/plasreconsurg/… #aestheticmedicine
Discussion: Natrelle Round Silicone Breast Implants: Core Study Results at 10 Years journals.lww.com/plasreconsurg/… @natrelle #cosmeticsurgery
Long term data, this is what #cosmeticsurgery need! Natrelle Round Breast Implants: 10 Years results journals.lww.com/plasreconsurg/… @natrelle
Key Insights into #cosmeticsurgery #cosmeticdermatology Lift-and-Fill Face Lift: Integrating the Fat Compartments journals.lww.com/plasreconsurg/…
Valeant ups bid for Allergan – big, bold, but lacking imagination? Eventually but only success will prevail!!
firstwordpharma.com/node/1213469
Valeant to divest dermatology product rights to Nestle Skin Health for $1.4 billion – firstwordpharma.com/node/1213243 @Galderma @Nestle #dermatology
Valeant’s bid 4 Allergan raises cash component.Made easier after Nestle yesterday Skin health deal @Nestle @Galderma firstwordpharma.com/node/1213347